Cargando…

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has highlighted the need for vaccines that not only prevent disease but also prevent transmission. Parenteral vaccines induce robust systemic immunity but poor immunity at the respiratory mucosa. We developed a vaccine strateg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Tianyang, Israelow, Benjamin, Peña-Hernández, Mario A., Suberi, Alexandra, Zhou, Liqun, Luyten, Sophia, Reschke, Melanie, Dong, Huiping, Homer, Robert J., Saltzman, W. Mark, Iwasaki, Akiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798903/ https://www.ncbi.nlm.nih.gov/pubmed/36302057 http://dx.doi.org/10.1126/science.abo2523

Ejemplares similares

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Isolation of Bat Sarbecoviruses, Japan
por: Murakami, Shin, et al.
Publicado: (2022)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
por: Martinez, David R., et al.
Publicado: (2021)

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
por: Martinez, David R., et al.
Publicado: (2021)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
por: Hurlburt, Nicholas K., et al.
Publicado: (2022)

Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2
por: Ma, Yong, et al.
Publicado: (2023)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models
por: Yuen, Chun-Kit, et al.
Publicado: (2023)

The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint
por: Guo, Hua, et al.
Publicado: (2022)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022)

Multiscale integration of human and single-cell variations reveals unadjuvanted vaccine high responders are naturally adjuvanted
por: Mulè, Matthew P., et al.
Publicado: (2023)

Superimmunity by pan-sarbecovirus nanobodies
por: Xiang, Yufei, et al.
Publicado: (2022)

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
por: Israelow, Benjamin, et al.
Publicado: (2020)

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
por: Israelow, Benjamin, et al.
Publicado: (2020)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
por: An, Xingyue, et al.
Publicado: (2021)

Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
por: Jensen, Jaime L., et al.
Publicado: (2023)

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
por: Israelow, Benjamin, et al.
Publicado: (2021)

Type 2 Dendritic Cells Orchestrate a Local Immune Circuit to Confer Antimetastatic Immunity
por: Weizman, Orr-El, et al.
Publicado: (2023)

Recombination in sarbecovirus lineage and mutations/insertions in spike protein are linked to the emergence and adaptation of SARS-CoV-2
por: Som, Anup, et al.
Publicado: (2022)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

A Multitrait Locus Regulates Sarbecovirus Pathogenesis
por: Schäfer, Alexandra, et al.
Publicado: (2022)

A comprehensive dataset of animal-associated sarbecoviruses
por: Liu, Bo, et al.
Publicado: (2023)

Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
por: Wec, Anna Z., et al.
Publicado: (2020)

Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine
por: Halfmann, Peter J., et al.
Publicado: (2023)

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
por: Wang, Yingdan, et al.
Publicado: (2022)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

Novel attempts launched toward universal Sarbecovirus vaccine
por: Li, Haoyang, et al.
Publicado: (2021)

Genomic Bootstrap Barcodes and Their Application to Study the Evolution of Sarbecoviruses
por: Hassanin, Alexandre, et al.
Publicado: (2022)

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
por: Starr, Tyler N., et al.
Publicado: (2022)

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
por: Burnett, Deborah L., et al.
Publicado: (2021)

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
por: Liu, Zezhong, et al.
Publicado: (2022)

Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan
por: Murakami, Shin, et al.
Publicado: (2020)

AS03-Adjuvanted, Very-Low-Dose Influenza Vaccines Induce Distinctive Immune Responses Compared to Unadjuvanted High-Dose Vaccines in BALB/c Mice
por: Yam, Karen K., et al.
Publicado: (2015)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen
por: Qiu, Sugan, et al.
Publicado: (2014)

Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
por: Li, Letian, et al.
Publicado: (2021)

Sarbecovirus ORF6 proteins hamper induction of interferon signaling
por: Kimura, Izumi, et al.
Publicado: (2021)

Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization
por: Lv, Huibin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a1hls4d3jkckr6oojpso2vfqd4